Annual CFO
$4.24 B
-$3.35 B-44.10%
31 December 2023
Summary:
Eli Lilly and Company annual cash flow from operations is currently $4.24 billion, with the most recent change of -$3.35 billion (-44.10%) on 31 December 2023. During the last 3 years, it has fallen by -$2.26 billion (-34.76%). LLY annual CFO is now -44.10% below its all-time high of $7.59 billion, reached on 31 December 2022.LLY Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFO
$3.71 B
+$2.25 B+153.16%
30 September 2024
Summary:
Eli Lilly and Company quarterly cash flow from operations is currently $3.71 billion, with the most recent change of +$2.25 billion (+153.16%) on 30 September 2024. Over the past year, it has increased by +$1.52 billion (+69.53%). LLY quarterly CFO is now at all-time high.LLY Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFO
$6.03 B
+$1.52 B+33.76%
30 September 2024
Summary:
Eli Lilly and Company TTM cash flow from operations is currently $6.03 billion, with the most recent change of +$1.52 billion (+33.76%) on 30 September 2024. Over the past year, it has dropped by -$182.50 million (-2.94%). LLY TTM CFO is now -26.36% below its all-time high of $8.19 billion, reached on 31 March 2022.LLY TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
LLY Cash From Operations Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | -44.1% | +69.5% | -2.9% |
3 y3 years | -34.8% | +127.5% | -12.8% |
5 y5 years | -23.3% | +145.8% | +39.6% |
LLY Cash From Operations High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3 years | -44.1% | at low | at high | +1290.1% | -26.4% | +64.1% |
5 y | 5 years | -44.1% | at low | at high | +1290.1% | -26.4% | +64.1% |
alltime | all time | -44.1% | +310.6% | at high | +1077.8% | -26.4% | +1901.4% |
Eli Lilly And Company Cash From Operations History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sept 2024 | - | $3.71 B(+153.2%) | $6.03 B(+33.8%) |
June 2024 | - | $1.47 B(+25.7%) | $4.51 B(+22.7%) |
Mar 2024 | - | $1.17 B(-473.8%) | $3.68 B(-13.3%) |
Dec 2023 | $4.24 B(-44.1%) | -$311.90 M(-114.2%) | $4.24 B(-31.8%) |
Sept 2023 | - | $2.19 B(+246.5%) | $6.21 B(-0.4%) |
June 2023 | - | $631.90 M(-63.5%) | $6.24 B(-8.1%) |
Mar 2023 | - | $1.73 B(+4.1%) | $6.79 B(-10.4%) |
Dec 2022 | $7.59 B(+3.0%) | $1.66 B(-25.0%) | $7.59 B(-7.3%) |
Sept 2022 | - | $2.22 B(+87.3%) | $8.18 B(+7.7%) |
June 2022 | - | $1.18 B(-53.1%) | $7.60 B(-7.2%) |
Mar 2022 | - | $2.52 B(+11.6%) | $8.19 B(+11.2%) |
Dec 2021 | $7.37 B(+13.3%) | $2.26 B(+38.6%) | $7.37 B(+6.5%) |
Sept 2021 | - | $1.63 B(-8.1%) | $6.92 B(-2.5%) |
June 2021 | - | $1.78 B(+4.6%) | $7.09 B(-9.2%) |
Mar 2021 | - | $1.70 B(-6.5%) | $7.81 B(+20.2%) |
Dec 2020 | $6.50 B(+34.4%) | $1.82 B(+0.5%) | $6.50 B(-2.2%) |
Sept 2020 | - | $1.81 B(-27.6%) | $6.65 B(+4.7%) |
June 2020 | - | $2.50 B(+552.6%) | $6.35 B(+29.4%) |
Mar 2020 | - | $382.40 M(-80.5%) | $4.91 B(+1.5%) |
Dec 2019 | $4.84 B(-12.5%) | $1.96 B(+30.0%) | $4.84 B(+11.9%) |
Sept 2019 | - | $1.51 B(+43.6%) | $4.32 B(-12.4%) |
June 2019 | - | $1.05 B(+237.8%) | $4.93 B(-8.6%) |
Mar 2019 | - | $311.30 M(-78.5%) | $5.40 B(-2.3%) |
Dec 2018 | $5.52 B(-1.6%) | $1.45 B(-31.7%) | $5.52 B(-5.1%) |
Sept 2018 | - | $2.12 B(+39.8%) | $5.82 B(+4.3%) |
June 2018 | - | $1.52 B(+247.7%) | $5.58 B(-2.3%) |
Mar 2018 | - | $436.50 M(-75.0%) | $5.71 B(+1.7%) |
Dec 2017 | $5.62 B(+15.8%) | $1.74 B(-7.3%) | $5.62 B(-4.5%) |
Sept 2017 | - | $1.88 B(+13.9%) | $5.88 B(+3.9%) |
June 2017 | - | $1.65 B(+385.8%) | $5.66 B(+4.6%) |
Mar 2017 | - | $339.90 M(-83.1%) | $5.41 B(+11.5%) |
Dec 2016 | $4.85 B(+63.6%) | $2.01 B(+20.7%) | $4.85 B(+26.3%) |
Sept 2016 | - | $1.66 B(+18.5%) | $3.84 B(+17.0%) |
June 2016 | - | $1.40 B(-739.8%) | $3.28 B(+16.0%) |
Mar 2016 | - | -$219.10 M(-122.0%) | $2.83 B(-4.5%) |
Dec 2015 | $2.96 B(-33.5%) | $996.10 M(-9.8%) | $2.96 B(-13.0%) |
Sept 2015 | - | $1.10 B(+16.5%) | $3.41 B(-14.7%) |
June 2015 | - | $948.60 M(-1218.6%) | $4.00 B(-2.6%) |
Mar 2015 | - | -$84.80 M(-105.9%) | $4.10 B(-8.0%) |
Dec 2014 | $4.46 B(-22.3%) | $1.44 B(-14.8%) | $4.46 B(-6.0%) |
Sept 2014 | - | $1.69 B(+60.5%) | $4.74 B(-6.0%) |
June 2014 | - | $1.05 B(+287.0%) | $5.04 B(-10.4%) |
Mar 2014 | - | $272.30 M(-84.2%) | $5.63 B(-1.9%) |
Dec 2013 | $5.74 B(+8.1%) | $1.73 B(-13.3%) | $5.74 B(+2.2%) |
Sept 2013 | - | $1.99 B(+21.6%) | $5.61 B(+8.7%) |
June 2013 | - | $1.64 B(+331.5%) | $5.16 B(+6.9%) |
Mar 2013 | - | $379.40 M(-76.3%) | $4.83 B(-8.9%) |
Dec 2012 | $5.30 B(-26.7%) | $1.60 B(+3.7%) | $5.30 B(-6.1%) |
Sept 2012 | - | $1.54 B(+18.2%) | $5.65 B(-8.6%) |
June 2012 | - | $1.31 B(+53.2%) | $6.18 B(-10.6%) |
Mar 2012 | - | $852.50 M(-56.2%) | $6.91 B(-4.5%) |
Dec 2011 | $7.23 B(+5.5%) | $1.94 B(-6.2%) | $7.23 B(-3.8%) |
Sept 2011 | - | $2.07 B(+1.6%) | $7.52 B(+4.4%) |
June 2011 | - | $2.04 B(+73.5%) | $7.20 B(+1.8%) |
Mar 2011 | - | $1.18 B(-47.2%) | $7.07 B(+3.2%) |
Dec 2010 | $6.86 B(+58.2%) | $2.23 B(+26.7%) | $6.86 B(+3.2%) |
Sept 2010 | - | $1.76 B(-8.0%) | $6.65 B(+7.3%) |
June 2010 | - | $1.91 B(+99.5%) | $6.19 B(+19.0%) |
Mar 2010 | - | $958.00 M(-52.5%) | $5.21 B(+20.1%) |
Dec 2009 | $4.34 B(-40.6%) | $2.02 B(+54.6%) | $4.34 B(-7.7%) |
Sept 2009 | - | $1.31 B(+41.4%) | $4.70 B(-15.0%) |
June 2009 | - | $923.30 M(+950.4%) | $5.52 B(-2.8%) |
Mar 2009 | - | $87.90 M(-96.3%) | $5.68 B(-22.1%) |
Dec 2008 | $7.30 B(+41.5%) | $2.38 B(+11.7%) | $7.30 B(+2.1%) |
Sept 2008 | - | $2.13 B(+97.2%) | $7.14 B(+10.6%) |
June 2008 | - | $1.08 B(-36.5%) | $6.46 B(+8.3%) |
Mar 2008 | - | $1.70 B(-23.6%) | $5.97 B(+15.7%) |
Dec 2007 | $5.15 B | $2.23 B(+54.4%) | $5.15 B(+7.8%) |
Sept 2007 | - | $1.44 B(+145.5%) | $4.78 B(+5.9%) |
June 2007 | - | $588.50 M(-34.0%) | $4.51 B(-2.2%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Mar 2007 | - | $891.80 M(-52.0%) | $4.61 B(+16.0%) |
Dec 2006 | $3.98 B(+107.8%) | $1.86 B(+58.0%) | $3.98 B(+35.6%) |
Sept 2006 | - | $1.18 B(+71.0%) | $2.93 B(+113.0%) |
June 2006 | - | $687.70 M(+170.2%) | $1.38 B(+1.0%) |
Mar 2006 | - | $254.50 M(-68.7%) | $1.36 B(-28.8%) |
Dec 2005 | $1.91 B(-33.3%) | $814.30 M(-314.5%) | $1.91 B(+16.1%) |
Sept 2005 | - | -$379.60 M(-156.3%) | $1.65 B(-41.7%) |
June 2005 | - | $674.10 M(-16.2%) | $2.83 B(-8.7%) |
Mar 2005 | - | $804.80 M(+46.8%) | $3.10 B(+7.9%) |
Dec 2004 | $2.87 B(-21.3%) | $548.40 M(-31.4%) | $2.87 B(-17.7%) |
Sept 2004 | - | $799.90 M(-15.3%) | $3.49 B(-7.0%) |
June 2004 | - | $944.20 M(+63.6%) | $3.75 B(+3.2%) |
Mar 2004 | - | $577.00 M(-50.5%) | $3.63 B(-0.3%) |
Dec 2003 | $3.65 B(+76.1%) | $1.17 B(+9.7%) | $3.65 B(+14.9%) |
Sept 2003 | - | $1.06 B(+28.4%) | $3.18 B(+18.4%) |
June 2003 | - | $828.00 M(+40.6%) | $2.68 B(+10.7%) |
Mar 2003 | - | $589.00 M(-15.3%) | $2.42 B(+16.9%) |
Dec 2002 | $2.07 B(-43.4%) | $695.00 M(+22.1%) | $2.07 B(-15.7%) |
Sept 2002 | - | $569.20 M(+0.2%) | $2.46 B(-15.9%) |
June 2002 | - | $568.30 M(+138.6%) | $2.92 B(-13.4%) |
Mar 2002 | - | $238.20 M(-78.0%) | $3.37 B(-7.9%) |
Dec 2001 | $3.66 B(-1.9%) | $1.08 B(+4.6%) | $3.66 B(+0.0%) |
Sept 2001 | - | $1.03 B(+1.3%) | $3.66 B(-5.3%) |
June 2001 | - | $1.02 B(+93.3%) | $3.87 B(+6.0%) |
Mar 2001 | - | $527.60 M(-51.1%) | $3.65 B(-2.2%) |
Dec 2000 | $3.73 B(+42.4%) | $1.08 B(-12.9%) | $3.73 B(+3.6%) |
Sept 2000 | - | $1.24 B(+54.8%) | $3.60 B(+5.2%) |
June 2000 | - | $801.10 M(+31.3%) | $3.42 B(+2.5%) |
Mar 2000 | - | $610.20 M(-35.8%) | $3.34 B(+27.5%) |
Dec 1999 | $2.62 B(-0.4%) | $951.20 M(-10.4%) | $2.62 B(-3.8%) |
Sept 1999 | - | $1.06 B(+48.2%) | $2.72 B(+11.4%) |
June 1999 | - | $716.30 M(-756.0%) | $2.45 B(-0.7%) |
Mar 1999 | - | -$109.20 M(-110.3%) | $2.46 B(-6.3%) |
Dec 1998 | $2.63 B(+9.6%) | $1.06 B(+34.8%) | $2.63 B(+3.8%) |
Sept 1998 | - | $782.90 M(+6.6%) | $2.53 B(+12.9%) |
June 1998 | - | $734.10 M(+1181.2%) | $2.24 B(+4.2%) |
Mar 1998 | - | $57.30 M(-94.0%) | $2.15 B(-10.3%) |
Dec 1997 | $2.40 B(+20.5%) | $959.00 M(+94.0%) | $2.40 B(+11.9%) |
Sept 1997 | - | $494.30 M(-23.2%) | $2.14 B(+0.7%) |
June 1997 | - | $643.40 M(+111.9%) | $2.13 B(+2.7%) |
Mar 1997 | - | $303.70 M(-56.8%) | $2.07 B(+4.2%) |
Dec 1996 | $1.99 B(+9.1%) | $703.40 M(+46.4%) | $1.99 B(-3.1%) |
Sept 1996 | - | $480.40 M(-18.1%) | $2.05 B(+9.0%) |
June 1996 | - | $586.60 M(+165.4%) | $1.89 B(+7.0%) |
Mar 1996 | - | $221.00 M(-71.2%) | $1.76 B(-3.4%) |
Dec 1995 | $1.82 B(+19.1%) | $766.60 M(+146.3%) | $1.82 B(+14.0%) |
Sept 1995 | - | $311.20 M(-32.8%) | $1.60 B(-10.7%) |
June 1995 | - | $463.00 M(+63.1%) | $1.79 B(+8.7%) |
Mar 1995 | - | $283.80 M(-47.7%) | $1.65 B(+7.6%) |
Dec 1994 | $1.53 B(+1.0%) | $542.70 M(+8.0%) | $1.53 B(+0.9%) |
Sept 1994 | - | $502.30 M(+57.4%) | $1.52 B(+0.7%) |
June 1994 | - | $319.20 M(+89.9%) | $1.51 B(-0.2%) |
Mar 1994 | - | $168.10 M(-68.2%) | $1.51 B(-0.5%) |
Dec 1993 | $1.52 B(+2.3%) | $528.30 M(+7.5%) | $1.52 B(-10.2%) |
Sept 1993 | - | $491.30 M(+52.6%) | $1.69 B(+17.4%) |
June 1993 | - | $322.00 M(+83.7%) | $1.44 B(+3.5%) |
Mar 1993 | - | $175.30 M(-75.0%) | $1.39 B(-6.3%) |
Dec 1992 | $1.48 B(+18.2%) | $699.90 M(+190.4%) | $1.48 B(+21.5%) |
Sept 1992 | - | $241.00 M(-11.8%) | $1.22 B(-15.9%) |
June 1992 | - | $273.20 M(+1.4%) | $1.45 B(+8.6%) |
Mar 1992 | - | $269.40 M(-38.4%) | $1.34 B(+6.4%) |
Dec 1991 | $1.25 B(-14.9%) | $437.00 M(-7.3%) | $1.25 B(-0.3%) |
Sept 1991 | - | $471.40 M(+198.9%) | $1.26 B(-1.2%) |
June 1991 | - | $157.70 M(-16.3%) | $1.27 B(-6.4%) |
Mar 1991 | - | $188.50 M(-57.3%) | $1.36 B(-7.7%) |
Dec 1990 | $1.47 B(+42.8%) | $441.10 M(-9.4%) | $1.47 B(+42.7%) |
Sept 1990 | - | $486.60 M(+98.4%) | $1.03 B(+89.0%) |
June 1990 | - | $245.30 M(-18.6%) | $546.70 M(+81.4%) |
Mar 1990 | - | $301.40 M | $301.40 M |
Dec 1989 | $1.03 B | - | - |
FAQ
- What is Eli Lilly and Company annual cash flow from operations?
- What is the all time high annual CFO for Eli Lilly and Company?
- What is Eli Lilly and Company annual CFO year-on-year change?
- What is Eli Lilly and Company quarterly cash flow from operations?
- What is the all time high quarterly CFO for Eli Lilly and Company?
- What is Eli Lilly and Company quarterly CFO year-on-year change?
- What is Eli Lilly and Company TTM cash flow from operations?
- What is the all time high TTM CFO for Eli Lilly and Company?
- What is Eli Lilly and Company TTM CFO year-on-year change?
What is Eli Lilly and Company annual cash flow from operations?
The current annual CFO of LLY is $4.24 B
What is the all time high annual CFO for Eli Lilly and Company?
Eli Lilly and Company all-time high annual cash flow from operations is $7.59 B
What is Eli Lilly and Company annual CFO year-on-year change?
Over the past year, LLY annual cash flow from operations has changed by -$3.35 B (-44.10%)
What is Eli Lilly and Company quarterly cash flow from operations?
The current quarterly CFO of LLY is $3.71 B
What is the all time high quarterly CFO for Eli Lilly and Company?
Eli Lilly and Company all-time high quarterly cash flow from operations is $3.71 B
What is Eli Lilly and Company quarterly CFO year-on-year change?
Over the past year, LLY quarterly cash flow from operations has changed by +$1.52 B (+69.53%)
What is Eli Lilly and Company TTM cash flow from operations?
The current TTM CFO of LLY is $6.03 B
What is the all time high TTM CFO for Eli Lilly and Company?
Eli Lilly and Company all-time high TTM cash flow from operations is $8.19 B
What is Eli Lilly and Company TTM CFO year-on-year change?
Over the past year, LLY TTM cash flow from operations has changed by -$182.50 M (-2.94%)